Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Malignant Neoplasm × Rifampin × Other neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Advanced Malignant Neoplasm 1

Interventions

tipifarnib 1 soybean oil, phospholipid emulsion 1 penpulimab 1 Sunscreening Agents 1 Spironolactone 1 Sorafenib 1 Rifampin 1 Morphine 1 Methods 1 Itraconazole 1 Irinotecan 1 Injections 1 Infusions, Intravenous 1 Hydrocortisone 1 Genetic Testing 1 Genetic Counseling 1 Fat Emulsions, Intravenous 1 Educational Status 1 Early Intervention, Educational 1 Doxycycline 1 Docetaxel 1 Counseling 1 Cordotomy 1 Acetates 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06165822 2023-12-12

A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Unknown

Advanced Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡